Several cytoskeleton proteins have been linked to CHD or related malformations, such as the association of decreased maternal plasma transthyretin with fetal Down syndrome accompanied by CHDs [28, 29], and four cytoskeleton proteins in maternal plasma as potential biomarkers for detecting CHDs in offspring. The gene discussed is TTR; the disease is Down syndrome.